Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 19.79B
March 31, 2026 19.85B
December 31, 2025 20.06B
September 30, 2025 21.07B
June 30, 2025 21.05B
March 31, 2025 21.30B
December 31, 2024 25.78B
September 30, 2024 26.68B
June 30, 2024 26.31B
March 31, 2024 27.79B
December 31, 2023 28.28B
September 30, 2023 30.66B
June 30, 2023 27.88B
March 31, 2023 28.29B
December 31, 2022 28.29B
September 30, 2022 27.96B
June 30, 2022 31.83B
March 31, 2022 32.72B
December 31, 2021 33.52B
September 30, 2021 19.81B
June 30, 2021 19.68B
March 31, 2021 19.47B
December 31, 2020 20.02B
September 30, 2020 20.10B
June 30, 2020 19.46B
Date Value
March 31, 2020 19.08B
December 31, 2019 18.19B
September 30, 2019 17.30B
June 30, 2019 17.54B
March 31, 2019 16.35B
December 31, 2018 15.72B
September 30, 2018 16.85B
June 30, 2018 16.58B
March 31, 2018 16.89B
December 31, 2017 17.11B
September 30, 2017 17.54B
June 30, 2017 16.96B
March 31, 2017 15.66B
December 31, 2016 15.55B
September 30, 2016 15.80B
June 30, 2016 15.98B
March 31, 2016 17.35B
December 31, 2015 20.96B
September 30, 2015 20.17B
June 30, 2015 30.02B
March 31, 2015 24.86B
December 31, 2014 26.14B
September 30, 2014 25.56B
June 30, 2014 25.63B
March 31, 2014 25.26B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
DexCom, Inc. 6.455B
Becton, Dickinson & Co. 50.73B
Boston Scientific Corp. 45.22B
West Pharmaceutical Services, Inc. 4.076B
Abbott Laboratories 109.22B

Total Assets (Quarterly) Related Metrics